Clinical trial
REduCing Immunogenicity to PegloticasE (RECIPE) Study
NCT03303989 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- REduCing Immunogenicity to PegloticasE (RECIPE) Study
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 14, 2018
- Completion date
- March 31, 2021
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gout chronic